US2005026140A1PendingUtilityA1

Taxonomic identification of pathogenic microorganisms and their toxic proteins

Priority: Nov 1, 2001Filed: Nov 12, 2003Published: Feb 3, 2005
Est. expiryNov 1, 2021(expired)· nominal 20-yr term from priority
B01J 20/3219B01J 20/3217B01J 20/3242G01N 33/54333C12Q 1/04
45
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention describes a method for the binding of pathogenic microorganisms and their toxic proteins with ligands that have been covalently tethered at some distance from the surface of a substrate: distances of at least fifteen Å are required for microorganism binding ligand tethers and at least six Å are required for protein binding ligand tethers. The ligands described herein include heme compounds, siderophores, polysaccharides, and peptides specific for toxic proteins, outer membrane proteins and conjugated lipids. Non-binding components of the solution to be analyzed are separated from the bound fraction and binding is confirmed by detection of the analyte via microscopy, fluorescence, epifluorescence, luminescence, phosphorescence, radioactivity, or optical absorbance. By patterning numerous ligands in an array on a substrate surface it is possible to taxonomically identify the microorganism by analysis of the binding pattern of the sample to the array.

Claims

exact text as granted — not AI-modified
38 . A method for taxonomic identification of a biological analyte comprising: 
 (a) exposing the solution containing the analyte to a ligand specific for the analyte of interest that has been conjugated to a marker;    (b) separating the bound analyte from the excess marker-conjugated ligands;    (c) interrogation of the analyte for ligand binding via detection of the conjugated marker.    
     
     
         39 . The method of  claim 38 , wherein the biological analyte is selected from the group comprised of: 
 (d) bacteria;    (e) viruses;    (f) proteinaceous toxin;    (g) rickettsiae;    (h) protozoa;    (i) fungi; and    (j) cytosolic protein.    
     
     
         40 . The method of  claim 38 , wherein the separation of the bound analyte from the excess conjugated ligand is accomplished by chromatography.  
     
     
         41 . The method of  claim 38 , wherein the ligand is conjugated to a magnetic particle and the separation of the bound analyte from the non-binding components of the analyte solution is accomplished by magnetic separation with the ligand being tethered to the magnetic particle by at least fifteen Å for capture of microorganisms.  
     
     
         42 . The method of  claim 38 , wherein the ligand is a heme compound.  
     
     
         43 . The method of  claim 38 , wherein the ligand is a siderophore.  
     
     
         44 . The method of  claim 38 , wherein the ligand is a polysaccharide.  
     
     
         45 . The method of  claim 38 , wherein the ligand is a peptide specific for an outer membrane protein.  
     
     
         46 . The method of  claim 38 , wherein the ligand is a peptide specific for a conjugated lipid.  
     
     
         47 . The method of  claim 38 , wherein the marker is fluorescent and the detection is via fluorescence.  
     
     
         48 . The method of  claim 38 , wherein the marker is luminescent and the detection is via luminescence.  
     
     
         49 . The method of  claim 38 , wherein the marker is radioactive and the detection is via radioactivity.  
     
     
         50 . The method of  claim 38 , wherein the marker is phosphorescent and the detection is via phosphorescence;

Join the waitlist — get patent alerts

Track US2005026140A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.